ArticleFundamental research2025

A tetramethylpyrazine releasing hydrogel can potentiate CAR-T cell therapy against triple negative breast cancer by reprogramming tumor vasculatures.

Yan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.